Search results
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta , initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
1 day ago · Torrent Pharmaceuticals Q1 Results Live : Torrent Pharmaceuticals declared their Q1 results on 23 Jul, 2024. The topline increased by 10.34% & the profit increased by 20.9% YoY.
1 day ago · Torrent Pharmaceuticals has delivered 6.26% return in the last 1 week, 25.88% return in the last 6 months and 36.14% YTD return. Currently, Torrent Pharmaceuticals has a market cap of ₹ 106227.9 ...
Torrent Pharma's competitive advantage stems from the world-class manufacturing facilities, advanced R & D capabilities, extensive domestic network and a widespread global presence in over 50 countries.
The Torrent Group, founded by Late Mr. U. N. Mehta in 1959 and currently lead by Mr. Sudhir Mehta and Mr. Samir Mehta, is a driving force dedicated to transforming life. It was five decades ago that Mr. U. N. Mehta embarked on a journey called Torrent for a simple cause and a unique sense of purpose - ‘Happiness for All’.
Torrent Pharma Share Price: Find the latest news on Torrent Pharma Stock Price. Get all the information on Torrent Pharma with historic price charts for NSE / BSE.
6 days ago · Torrent Pharmaceuticals Limited Stock Price Today, Live NSE Share Price: Get the latest Torrent Pharmaceuticals Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
6 days ago · Torrent Pharma Share Price Today (23 Jul, 2024): Torrent Pharma Stock Price (₹ 3138.70) Live NSE/BSE updates on The Economic Times. Check out why Torrent Pharma share price is up today. Get all details on Torrent Pharmaceuticals Ltd.shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report ...
Get the latest Torrent Pharmaceuticals Ltd (TORNTPHARM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...
1 day ago · Torrent Pharma reported a 21 per cent year-on-year (Y-o-Y) rise in consolidated net profit for the June quarter (Q1 FY25) to Rs 457 crore, up from Rs 378 crore reported for the same period last year. The company’s revenue from operations rose to Rs 2,859 crore in Q1 FY25, a 10 per cent Y-o-Y ...
Oct 23, 2023 · Indian drugmaker Torrent Pharmaceuticals on Monday reported a nearly 24% jump in second-quarter profit, driven by the strong demand in the domestic market and in Brazil.
1 day ago · Net profit of Torrent Pharmaceuticals rose 20.90% to Rs 457.00 crore in the quarter ended June 2024 as against Rs 378.00 crore during the previous quarter ended June 2023. Sales rose 10.48% to Rs 2815.00 crore in the quarter ended June 2024 as against Rs 2548.00 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales2815.002548.00 10 OPM %32.1131.04 -PBDT853.00722.00 18 PBT656.00531.00 24 NP457.00378.00 21 .
Oct 27, 2023 · The latest international Torrent Pharmaceuticals Ltd news and views from Reuters - one of the world's largest news agencies.
1 day ago · Torrent Pharma shares closed at 3,138.70 on July 23, 2024 (NSE) and has given 25.88% returns over the last 6 months and 61.71% over the last 12 months. Torrent Pharmaceuticals:
T orrent Pharma on Tuesday reported a 21% year-on-year (YoY) jump in net profit Rs 457 crore in Q1FY25 led by sales momentum in India and Germany. The company reported net profit of Rs 378 crore ...
Torrent Pharmaceuticals Ltd | 215,648 followers on LinkedIn. Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group...
Torrent Pharmaceuticals Ltd. Share Price Today: CLOSE 2939.1, HIGH 3079, LOW: 2937.15. Get latest balance sheet, annual reports, quarterly results, and price chart.
Torrent Pharma today has a strong presence in various therapeutic segments with seven world-class operational manufacturing plants and a state-of-the-art research centre. Torrent Pharma’s global operations are spread across 40 countries with wholly owned subsidiaries in most major markets.
Check out Torrent Pharmaceuticals share price and NSE/BSE details with 52-week high, 52-week low, Dividend, Technicals, Torrent Pharmaceuticals Quarterly Results, and more.
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.
Torrent Pharmaceuticals Ltd (Torrent) is a pharmaceuticals and healthcare company that manufactures and markets branded and unbranded generic pharmaceuticals. It provides products for the treatment of cardiovascular, central nervous system, gastro-intestinal and urological diseases, diabetes, infections, and pain management.
Be it finding a cure for fatal diseases or ambitious power generation projects; or setting new standards in transmission and distribution; breakthrough pharma discoveries; or setting up new milestones in EV charging infrastructure, city gas distribution network; green hydrogen initiatives; new-age pumped storage hydro projects; or 24X7 customer ...
Get Torrent Pharmaceuticals Ltd. share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding, and financial report.
1 day ago · Stocks including Hindustan Unilever, Vedanta, Dr Reddy's, L&T, Axis Bank, Torrent Pharma, Titagarh Railsystems, Bajaj Finance, USL and more will announce their quarterly results on Wednesday, July 24.
Jefferies on Torrent Pharma: Buy | Target price: Rs 3,540Jefferies has maintained a buy call on the stock and hiked the target price to Rs 3,540 from Rs 3,070.
Part 2, a randomized, double-blind study, investigated the pharmacokinetics (PK), safety and immunogenicity of study drugs (HLX02 [n = 37], CN-trastuzumab [n = 35] or EU-trastuzumab [n = 37] at the dose suggested by Part 1 results).
Aug 9, 2022 · This study also obtained clinical information and gene mRNA expression profiles from the TCGA database ( https://portal.gdc.cancer.gov) for 375 GC and 32 matched noncarcinoma samples. To be specific, the data extracted included age, gender, pathological stage, vital status, grade, and TNM stage.
1 day ago · Stocks to Buy Today, Hot Stocks on July 24, 2024: Shares of several companies including HCL Tech, Godrej Properties, Bajaj Finance, Torrent Pharma, and HUL, among others, will be in the news today ...
Alternative polyadenylation (APA) is a widespread mechanism generating RNA molecules with alternative 3' ends. Herein, we discovered that TargetScan includes a novel XBP1 transcript with a longer 3' untranslated region (UTR) (XBP1-UL) than that included in NCBI. XBP1-UL exhibited a lowered level in …
Lined with traditional shops, intricate architecture, and vibrant stalls, Guanqian Street beckons visitors on a journey through time. The street is a treasure trove of cultural experiences, where you can savor authentic Suzhou cuisine, shop for delicate silk garments, and immerse yourself in the local arts and crafts.
